ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

Malone Retires As NIH Deputy, Raub To Succeed Him

August 22, 1986

NCAB May Determine Fate Of NCOG, Possibly Other Regional Groups; Simone Denies CCIRC Prejudice

May 8, 1981

In Brief: Over Half Of Ovarian Cancer Patients Staged Incorrectly; Senate Gets Funding Resolution

April 12, 1985

IOM Panel Suggest Ways To Fund More Training, Construction

November 9, 1990

Lasagna Committee Urges Medicare Payment for Experimental Drugs, Care

September 29, 1989

Study Tracks Lifestyle Factors For Cancer Burden In Blacks

October 26, 2001